569 related articles for article (PubMed ID: 22036605)
1. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
[TBL] [Abstract][Full Text] [Related]
2. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
[TBL] [Abstract][Full Text] [Related]
3. Sleep-wakefulness effects after microinjections of hypocretin 1 (orexin A) in cholinoceptive areas of the cat oral pontine tegmentum.
Moreno-Balandrán E; Garzón M; Bódalo C; Reinoso-Suárez F; de Andrés I
Eur J Neurosci; 2008 Jul; 28(2):331-41. PubMed ID: 18702704
[TBL] [Abstract][Full Text] [Related]
4. Narcolepsy: pathophysiology and pharmacology.
Nishino S
J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
[TBL] [Abstract][Full Text] [Related]
5. Intranasal hypocretin-1: making sense of scents?
Lammers GJ
Sleep Med; 2011 Dec; 12(10):939-40. PubMed ID: 22136855
[No Abstract] [Full Text] [Related]
6. Narcolepsy in the older adult: epidemiology, diagnosis and management.
Chakravorty SS; Rye DB
Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
[TBL] [Abstract][Full Text] [Related]
7. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
Knudsen S; Gammeltoft S; Jennum PJ
Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
[TBL] [Abstract][Full Text] [Related]
8. [Hypocretin (orexin) deficiency in narcolepsy-cataplexy].
Nevsímalová S; Vanková J; Sonka K; Faraco J; Rogers W; Overeem S; Mignot E
Sb Lek; 2000; 101(4):381-6. PubMed ID: 11702580
[TBL] [Abstract][Full Text] [Related]
9. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate.
Mamelak M
Prog Neurobiol; 2009 Oct; 89(2):193-219. PubMed ID: 19654034
[TBL] [Abstract][Full Text] [Related]
10. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
[TBL] [Abstract][Full Text] [Related]
11. High-amplitude theta wave bursts during REM sleep and cataplexy in hypocretin-deficient narcoleptic mice.
Bastianini S; Silvani A; Berteotti C; Lo Martire V; Zoccoli G
J Sleep Res; 2012 Apr; 21(2):185-8. PubMed ID: 21883592
[TBL] [Abstract][Full Text] [Related]
12. Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs.
John J; Wu MF; Siegel JM
Sleep Res Online; 2000; 3(1):23-8. PubMed ID: 11382896
[TBL] [Abstract][Full Text] [Related]
13. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy.
Black SW; Morairty SR; Fisher SP; Chen TM; Warrier DR; Kilduff TS
Sleep; 2013 Mar; 36(3):325-36. PubMed ID: 23449602
[TBL] [Abstract][Full Text] [Related]
14. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates.
Willie JT; Renthal W; Chemelli RM; Miller MS; Scammell TE; Yanagisawa M; Sinton CM
Neuroscience; 2005; 130(4):983-95. PubMed ID: 15652995
[TBL] [Abstract][Full Text] [Related]
15. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
[TBL] [Abstract][Full Text] [Related]
16. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
Dauvilliers Y; Jennum P; Plazzi G
Sleep Med; 2013 Aug; 14(8):775-81. PubMed ID: 23219054
[TBL] [Abstract][Full Text] [Related]
17. Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1).
Baier PC; Weinhold SL; Huth V; Gottwald B; Ferstl R; Hinze-Selch D
Brain; 2008 Oct; 131(Pt 10):2734-41. PubMed ID: 18718966
[TBL] [Abstract][Full Text] [Related]
18. [Narcolepsy: a new perspective on diagnosis and treatment].
Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
20. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
Overeem S; Scammell TE; Lammers GJ
Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
